UnitedHealth Group reported strong Q4 and full-year 2016 results, exceeding expectations with double-digit revenue and earnings growth across all segments. Management expressed confidence for 2017, reaffirming optimistic guidance and highlighting strategic expansions like the acquisition of Surgical Care Affiliates and strong growth in Medicare Advantage. The positive financial performance and upbeat outlook are likely to have a positive short-term impact on the stock price.

[1]